Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02389244 |
|---|---|
| Brief Title: | A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas (REGOBONE) |
| First Submitted : | February 9, 2015 |
| First Submitted that Met QC Criteria : | March 16, 2015 |
| First Posted : | March 17, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 6, 2023 |
| Last Update Posted : | November 7, 2023 |